Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
00874
Company Profile
Business description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segments include Great Southern TCM; Great Health; Great Commerce and Great Medical Care. The company generates maximum revenue from the Great Commerce segment.
Contact
45 Sha Mian North Street
Liwan District
Guangdong Province
Guangzhou510130
CHNT: +86 2066281218
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
27,425
Stocks News & Analysis
stocks
Chart of the Week: Inflation fears dampen sentiment on retailers
Rising inflation is the fly in the ointment.
stocks
Here’s 3 Top Rated ASX shares for 2026
As we start the new year, let’s take a closer look at three compelling opportunities on the ASX
stocks
Undervalued Aussie e-commerce winner
Shares attractive due to near term profit margin increase and structural growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,046.50 | 22.30 | 0.25% |
| CAC 40 | 8,224.41 | 9.51 | -0.12% |
| DAX 40 | 25,151.76 | 29.50 | 0.12% |
| Dow JONES (US) | 48,996.08 | 466.00 | -0.94% |
| FTSE 100 | 10,033.28 | 14.93 | -0.15% |
| HKSE | 26,149.31 | 309.64 | -1.17% |
| NASDAQ | 23,584.28 | 37.10 | 0.16% |
| Nikkei 225 | 51,117.26 | 844.72 | -1.63% |
| NZX 50 Index | 13,716.86 | 1.84 | 0.01% |
| S&P 500 | 6,920.93 | 23.89 | -0.34% |
| S&P/ASX 200 | 8,720.80 | 18.20 | 0.21% |
| SSE Composite Index | 4,082.98 | 2.79 | -0.07% |